Exploration of Targeted Anti-tumor Therapy : Impact Factor & More
eISSN: 2692-3114
Open AccessShare this on:
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Exploration of Targeted Anti-tumor Therapy
Exploration of Targeted Anti-tumor Therapy Journal Specifications
Indexed in the following public directories
Scopus 
DOAJ 
SJR
| Overview | |
| Publisher | Open Exploration Publishing Inc. |
| Language | English |
| Publication Time | 13 |
| Editorial Review Process | Blind peer review |
| General Details | |
| Language | English |
| Website URL | Visit website |
| Publication Details | |
| Plagiarism | Visit website |
| Publication Time | 13 |
| Editorial Review Detail | |
| Information for authors | |
| Author instructions | Visit website |
| Copyright Details | Visit website |
| Deposit Policy | Sherpa/Romeo |
| License type | CC BY |
| OA statement | Visit website |
View less
Planning to publish in Exploration of Targeted Anti-tumor Therapy ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Exploration of Targeted Anti-tumor Therapy
The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review
- 27 Apr 2026
- Exploration of Targeted Anti-tumor Therapy
FDA 2025 Cancer Drug Approvals: targeted therapy dominates
- 27 Apr 2026
- Exploration of Targeted Anti-tumor Therapy
Solitary fibrous tumor of the lung: diagnostic challenges and surgical management.
- 21 Apr 2026
- Exploration of targeted anti-tumor therapy
Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC.
- 13 Apr 2026
- Exploration of targeted anti-tumor therapy
Survival prediction in triple-negative breast cancer: a Cox model with fairness assessment using ISO/IEC TR 24027:2021 in a MENA cohort
- 20 Mar 2026
- Exploration of Targeted Anti-tumor Therapy
Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer
- 9 Mar 2026
- Exploration of Targeted Anti-tumor Therapy
The evolving role of targeted radioligand therapy in small cell and non-small cell lung cancer: a systematic review
- 27 Apr 2026
- Exploration of Targeted Anti-tumor Therapy
FDA 2025 Cancer Drug Approvals: targeted therapy dominates
- 27 Apr 2026
- Exploration of Targeted Anti-tumor Therapy
Solitary fibrous tumor of the lung: diagnostic challenges and surgical management.
- 21 Apr 2026
- Exploration of targeted anti-tumor therapy
Changes of urinary immunity and microbiome after intravesical BCG therapy and their association with outcomes in NMIBC.
- 13 Apr 2026
- Exploration of targeted anti-tumor therapy
Survival prediction in triple-negative breast cancer: a Cox model with fairness assessment using ISO/IEC TR 24027:2021 in a MENA cohort
- 20 Mar 2026
- Exploration of Targeted Anti-tumor Therapy
Emerging roles of haemostatic proteins as markers of disease progression and prognosis in breast cancer
- 9 Mar 2026
- Exploration of Targeted Anti-tumor Therapy
FAQs on Exploration of Targeted Anti-tumor Therapy
How many articles did Exploration of Targeted Anti-tumor Therapy publish last year? 
Who is the publisher of Exploration of Targeted Anti-tumor Therapy?
